|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 7155 |
FusionGeneSummary for CHPT1_SCYL2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CHPT1_SCYL2 | Fusion gene ID: 7155 | Hgene | Tgene | Gene symbol | CHPT1 | SCYL2 | Gene ID | 56994 | 55681 |
| Gene name | choline phosphotransferase 1 | SCY1 like pseudokinase 2 | |
| Synonyms | CPT|CPT1 | CVAK104 | |
| Cytomap | 12q23.2 | 12q23.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cholinephosphotransferase 1AAPT1-like proteincholinephosphotransferase 1 alphadiacylglycerol cholinephosphotransferase 1hCPT1phosphatidylcholine synthesizing enzyme | SCY1-like protein 2SCY1-like 2SCY1-like, kinase-like 2coated vesicle-associated kinase of 104 kDa | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q8WUD6 | Q6P3W7 | |
| Ensembl transtripts involved in fusion gene | ENST00000550385, ENST00000229266, ENST00000549872, | ENST00000550067, ENST00000360820, | |
| Fusion gene scores | * DoF score | 6 X 4 X 4=96 | 3 X 3 X 3=27 |
| # samples | 6 | 3 | |
| ** MAII score | log2(6/96*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CHPT1 [Title/Abstract] AND SCYL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CHPT1 | GO:0006656 | phosphatidylcholine biosynthetic process | 10893425 |
| Hgene | CHPT1 | GO:0006663 | platelet activating factor biosynthetic process | 10893425 |
| Tgene | SCYL2 | GO:0002092 | positive regulation of receptor internalization | 19643732 |
| Tgene | SCYL2 | GO:0008333 | endosome to lysosome transport | 19643732 |
| Tgene | SCYL2 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 19643732 |
| Tgene | SCYL2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway | 19643732 |
| Tgene | SCYL2 | GO:2000370 | positive regulation of clathrin-dependent endocytosis | 19643732 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-A7-A4SC-01A | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000550385 | ENST00000550067 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| intron-3UTR | ENST00000550385 | ENST00000360820 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| intron-3UTR | ENST00000229266 | ENST00000550067 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| intron-3UTR | ENST00000229266 | ENST00000360820 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| intron-3UTR | ENST00000549872 | ENST00000550067 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
| intron-3UTR | ENST00000549872 | ENST00000360820 | CHPT1 | chr12 | 102124414 | + | SCYL2 | chr12 | 100685281 | + |
Top |
FusionProtFeatures for CHPT1_SCYL2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CHPT1 | SCYL2 |
| Component of AP2-containing clathrin coated structuresat the plasma membrane or of endocytic coated vesicles. Accordingto PubMed:15809293, probable serine/threonine-protein kinase thatphosphorylates, in vitro, the beta2-subunit of the plasma membraneadapter complex AP2 and other proteins in presence of poly-L-lysine. According to PubMed:16914521, has no detectable kinaseactivity in vitro. May regulate clathrin-dependent traffickingbetween the TGN and/or the endosomal system.{ECO:0000269|PubMed:15809293, ECO:0000269|PubMed:16914521}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHPT1_SCYL2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHPT1_SCYL2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CHPT1 | ELAVL1, KLK11, CD1B, TMEM171, GINM1, GPR52, SLAMF1, BSCL2, FAM189A2, ERGIC3, TCTN3, FPR2, SLC22A9, CD70, APLNR, OPRM1, SLC22A6, LRRC8B, CDH13, SLC39A5, TMEM5, SLC1A1, PDCD1, VASN, SPPL2B, NMUR2, CLEC2D, SLC5A8, SLC15A1 | SCYL2 | NOP56, ARRB1, ARRB2, SPEN, ESR1, MAGOH, EIF4A3, ZFYVE9, SOX2, FBXO6, RAPGEF2, CLTC, ALYREF, PCBP2, PCMT1, COX17, CTSD, SOD1, TALDO1, TKT, NTRK1, CNTROB, NINL, TMEM17, XPO1, GTSE1, CRY1, SNW1, CDC5L, CDH1, EGFR, SPATA1, GORASP2, SH3GLB1, CDK5, PRCC, SEPT7, DIS3, CHORDC1, SUB1, SARNP, UBAP2, COPZ1, SEPT11, PDLIM1, CDK1, COQ2, COX15, SOAT1, VDAC1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHPT1_SCYL2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHPT1_SCYL2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CHPT1 | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|